VDAC1 and glioblastoma: In summary, depleting VDAC1 effectively targeted radio- and chemo-resistant CSCs in GBM, breast cancer, and BC, leading to their differentiation into mature, non-replicating cells and, thereby, preventing tumor recurrence.